MSD Animal Health, known as Merck Animal Health in the United States and Canada, recently announced the introduction of FINADYNE®Transdermal (flunixin meglumine) Pour-on solution, which has created some confusion among our customers in the United States. To clarify, FINADYNE Transdermal is not approved or available for sale in the United States. We apologize for any inconvenience and confusion this has caused.
 
In the United States, flunixin meglumine is marketed as BANAMINE® Injectable Solution and in combination with florfenicol, as RESFLOR Gold®. For more information visit resflorgold.com.​